Back

SGLT2i is indicated for all HFpEF patients - con.

23 May 2022 (08:50 - 09:10)
Organised by:
Congress Presentation Part of: SGLT2i for HFpEF Chronic Heart Failure HFA Premium Access Heart Failure 2022

About the speaker

Photo
Professor Sivadasanpillai Harikrishnan

Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST), Thiruvananthapuram (India)

2 More presentations in this session

Presentation thumbnail
SGLT2i is indicated for all HFpEF patients - pro.
Professor A. Stewart Coats (Sydney, AU)
Slides Video
Presentation thumbnail
SGLT2i for HFpEF - rebuttal and discussion.
Video

Access the full session

Session thumbnail
SGLT2i for HFpEF
Video

The Event

Event poster

Heart Failure 2022

23 May 2022 08:50 CET
You may be interested in
thumbnail
Congress Presentation
A patient with HF and LVEF > 40%: SGLT2 inhibitors.
27 August 2022
thumbnail
Congress Session
Solving the puzzle of HFpEF: pearls for clinical management
23 May 2022
thumbnail
Congress Session
SGLT2 inhibitors in practice (part 2): how do we implement new treatments in HFpEF?
27 August 2022
thumbnail
Congress Session
Further Insights into SGLT2i treatment for heart failure
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources